Hunan Jingfeng Pharmaceutical (000908) — Working Capital to Net Assets Ratio
Hunan Jingfeng Pharmaceutical (000908) has a Working Capital to Net Assets ratio of 1273.4% as of September 2025. Working capital of CN¥-480.78 Million (current assets of CN¥307.14 Million minus current liabilities of CN¥787.92 Million) is measured against net assets of CN¥-37.76 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Hunan Jingfeng Pharmaceutical to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hunan Jingfeng Pharmaceutical Working Capital to Net Assets (1995–2024)
This chart shows how Hunan Jingfeng Pharmaceutical's Working Capital to Net Assets ratio has evolved across 30 annual periods from 1995 to 2024. As of September 2025, the ratio stands at 1273.4%, reflecting working capital of CN¥-480.78 Million against net assets of CN¥-37.76 Million CNY. See 000908 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Hunan Jingfeng Pharmaceutical (1995–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hunan Jingfeng Pharmaceutical from 1995 to 2024, covering 30 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 000908 market cap overview.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 4478.3% | CN¥-677.54 Million | CN¥-15.13 Million | CN¥227.19 Million | CN¥904.73 Million | ▲ +3939.7 pp |
| 2023 | 538.6% | CN¥-827.79 Million | CN¥-153.68 Million | CN¥213.76 Million | CN¥1.04 Billion | ▲ +777.0 pp |
| 2022 | -238.4% | CN¥-512.06 Million | CN¥214.83 Million | CN¥571.30 Million | CN¥1.08 Billion | ▼ -29.8 pp |
| 2021 | -208.6% | CN¥-683.57 Million | CN¥327.73 Million | CN¥677.51 Million | CN¥1.36 Billion | ▼ -77.5 pp |
| 2020 | -131.1% | CN¥-836.79 Million | CN¥638.18 Million | CN¥1.02 Billion | CN¥1.86 Billion | ▼ -137.1 pp |
| 2019 | 5.9% | CN¥115.23 Million | CN¥1.94 Billion | CN¥1.78 Billion | CN¥1.67 Billion | ▼ -36.2 pp |
| 2018 | 42.2% | CN¥1.21 Billion | CN¥2.86 Billion | CN¥2.59 Billion | CN¥1.38 Billion | ▼ -16.8 pp |
| 2017 | 59.0% | CN¥1.53 Billion | CN¥2.60 Billion | CN¥2.58 Billion | CN¥1.05 Billion | ▼ -13.9 pp |
| 2016 | 72.9% | CN¥1.91 Billion | CN¥2.61 Billion | CN¥3.20 Billion | CN¥1.29 Billion | ▲ +30.1 pp |
| 2015 | 42.9% | CN¥963.94 Million | CN¥2.25 Billion | CN¥1.93 Billion | CN¥969.66 Million | ▲ +15.4 pp |
| 2014 | 27.5% | CN¥273.35 Million | CN¥994.04 Million | CN¥1.07 Billion | CN¥797.85 Million | ▲ +3174.5 pp |
| 2013 | -3147.0% | CN¥-167.06 Million | CN¥5.31 Million | CN¥160.49 Million | CN¥327.55 Million | ▼ -3592.2 pp |
| 2012 | 445.2% | CN¥-267.80 Million | CN¥-60.15 Million | CN¥158.44 Million | CN¥426.24 Million | ▲ +27363.0 pp |
| 2011 | -26917.8% | CN¥-212.87 Million | CN¥790.82K | CN¥202.41 Million | CN¥415.28 Million | ▼ -26836.9 pp |
| 2010 | -80.9% | CN¥-46.80 Million | CN¥57.85 Million | CN¥247.62 Million | CN¥294.42 Million | ▲ +18.0 pp |
| 2009 | -98.9% | CN¥-99.57 Million | CN¥100.67 Million | CN¥232.32 Million | CN¥331.89 Million | ▼ -72.0 pp |
| 2008 | -26.9% | CN¥-90.99 Million | CN¥338.64 Million | CN¥359.31 Million | CN¥450.30 Million | ▼ -13.0 pp |
| 2007 | -13.8% | CN¥-46.65 Million | CN¥336.95 Million | CN¥424.50 Million | CN¥471.15 Million | ▲ +20.0 pp |
| 2006 | -33.8% | CN¥-113.85 Million | CN¥336.40 Million | CN¥372.22 Million | CN¥486.08 Million | ▼ -41.0 pp |
| 2005 | 7.2% | CN¥23.61 Million | CN¥329.66 Million | CN¥534.10 Million | CN¥510.48 Million | ▼ -21.7 pp |
| 2004 | 28.9% | CN¥98.08 Million | CN¥339.45 Million | CN¥631.18 Million | CN¥533.11 Million | ▼ -6.2 pp |
| 2003 | 35.1% | CN¥147.03 Million | CN¥419.38 Million | CN¥704.67 Million | CN¥557.64 Million | ▼ -3.4 pp |
| 2002 | 38.4% | CN¥200.96 Million | CN¥522.69 Million | CN¥534.94 Million | CN¥333.98 Million | ▼ -20.7 pp |
| 2001 | 59.2% | CN¥294.81 Million | CN¥498.41 Million | CN¥392.84 Million | CN¥98.02 Million | ▼ -1.5 pp |
| 2000 | 60.7% | CN¥303.83 Million | CN¥500.54 Million | CN¥454.41 Million | CN¥150.59 Million | ▼ -7.4 pp |
| 1999 | 68.1% | CN¥330.55 Million | CN¥485.43 Million | CN¥491.33 Million | CN¥160.78 Million | ▼ -12.3 pp |
| 1998 | 80.4% | CN¥322.14 Million | CN¥400.62 Million | CN¥360.47 Million | CN¥38.33 Million | ▲ +35.3 pp |
| 1997 | 45.1% | CN¥39.02 Million | CN¥86.51 Million | CN¥65.39 Million | CN¥26.37 Million | ▲ +21.1 pp |
| 1996 | 24.0% | CN¥14.59 Million | CN¥60.83 Million | CN¥74.31 Million | CN¥59.71 Million | ▼ -2.3 pp |
| 1995 | 26.3% | CN¥8.10 Million | CN¥30.79 Million | CN¥33.64 Million | CN¥25.54 Million | — |